The case for investing in healthcare startups
Despite their immense potential and positive impact, such startups struggle to attract funding
Add BT as a preferred source
SINGAPORE has seen significant growth in the number of startups and investments in the healthcare technology sector. Last year, Singapore’s healthtech startups raised US$409 million, with deal volume doubling from the previous year.
Across the globe, countries grapple with ageing populations, rising chronic disease burdens, and increasing healthcare costs. Conventional healthcare systems struggle to meet these demands – leaving room for startups that offer more efficient, cost-effective and patient-centric solutions.
Such startups harness innovations to tackle problems in traditional healthcare systems, improving patient outcomes, widening access and enhancing quality of care.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Koh Brothers Eco Engineering faces up to S$57.6 million in potential liabilities from legal disputes
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
DayOne secures S$530 million green loan from DBS, OCBC and UOB for Singapore data centre
